BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30837677)

  • 21. The volumetric-tumour histogram-based analysis of intravoxel incoherent motion and non-Gaussian diffusion MRI: association with prognostic factors in HER2-positive breast cancer.
    You C; Li J; Zhi W; Chen Y; Yang W; Gu Y; Peng W
    J Transl Med; 2019 Jul; 17(1):182. PubMed ID: 31262334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valproic acid inhibits proliferation of HER2-expressing breast cancer cells by inducing cell cycle arrest and apoptosis through Hsp70 acetylation.
    Mawatari T; Ninomiya I; Inokuchi M; Harada S; Hayashi H; Oyama K; Makino I; Nakagawara H; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
    Int J Oncol; 2015 Dec; 47(6):2073-81. PubMed ID: 26497673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of expression of heat shock proteins and apoptosis by Flueggea leucopyrus (Willd) decoction in three breast cancer phenotypes.
    Mendis AS; Thabrew I; Samarakoon SR; Tennekoon KH
    BMC Complement Altern Med; 2015 Nov; 15():404. PubMed ID: 26553005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.
    Vohra P; Buelow B; Chen YY; Serrano M; Vohra MS; Berry A; Ljung BM
    Cancer Cytopathol; 2016 Nov; 124(11):828-835. PubMed ID: 27315045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical requirements for the expression of heat shock protein 72 kda in human breast cancer MCF-7 cells.
    Kiang JG; Gist ID; Tsokos GC
    Mol Cell Biochem; 1999 Sep; 199(1-2):179-88. PubMed ID: 10544966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of heat stress on proliferation, protein turnover, and abundance of heat shock protein messenger ribonucleic acid in cultured porcine muscle satellite cells.
    Kamanga-Sollo E; Pampusch MS; White ME; Hathaway MR; Dayton WR
    J Anim Sci; 2011 Nov; 89(11):3473-80. PubMed ID: 21742942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The HSP90 inhibitor NVP-AUY922 inhibits growth of HER2 positive and trastuzumab-resistant breast cancer cells.
    Canonici A; Qadir Z; Conlon NT; Collins DM; O'Brien NA; Walsh N; Eustace AJ; O'Donovan N; Crown J
    Invest New Drugs; 2018 Aug; 36(4):581-589. PubMed ID: 29396630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of micrornas in molecular genetic breast cancer subtypes.
    Kolesnikov NN; Veryaskina YA; Titov SE; Rodionov VV; Gening TP; Abakumova TV; Kometova VV; Torosyan MK; Zhimulev IF
    Cancer Treat Res Commun; 2019; 20():100026. PubMed ID: 31255253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances.
    Muller P; Ruckova E; Halada P; Coates PJ; Hrstka R; Lane DP; Vojtesek B
    Oncogene; 2013 Jun; 32(25):3101-10. PubMed ID: 22824801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNAi knockdown of Hop (Hsp70/Hsp90 organising protein) decreases invasion via MMP-2 down regulation.
    Walsh N; Larkin A; Swan N; Conlon K; Dowling P; McDermott R; Clynes M
    Cancer Lett; 2011 Jul; 306(2):180-9. PubMed ID: 21470770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of B,C-ring truncated deguelin derivatives as heat shock protein 90 (HSP90) inhibitors for use as anti-breast cancer agents.
    Kim HS; Hoang VH; Hong M; Chul Kim K; Ann J; Nguyen CT; Seo JH; Choi H; Yong Kim J; Kim KW; Sub Byun W; Lee S; Lee S; Suh YG; Chen J; Park HJ; Cho TM; Kim JY; Seo JH; Lee J
    Bioorg Med Chem; 2019 Apr; 27(7):1370-1381. PubMed ID: 30827868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer.
    Srirangam A; Mitra R; Wang M; Gorski JC; Badve S; Baldridge L; Hamilton J; Kishimoto H; Hawes J; Li L; Orschell CM; Srour EF; Blum JS; Donner D; Sledge GW; Nakshatri H; Potter DA
    Clin Cancer Res; 2006 Mar; 12(6):1883-96. PubMed ID: 16551874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel chalcone-based molecule, BDP inhibits MDA‑MB‑231 triple-negative breast cancer cell growth by suppressing Hsp90 function.
    Oh YJ; Seo YH
    Oncol Rep; 2017 Oct; 38(4):2343-2350. PubMed ID: 28849241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical antitumor activity of the novel heat shock protein 90 inhibitor CH5164840 against human epidermal growth factor receptor 2 (HER2)-overexpressing cancers.
    Ono N; Yamazaki T; Nakanishi Y; Fujii T; Sakata K; Tachibana Y; Suda A; Hada K; Miura T; Sato S; Saitoh R; Nakano K; Tsukuda T; Mio T; Ishii N; Kondoh O; Aoki Y
    Cancer Sci; 2012 Feb; 103(2):342-9. PubMed ID: 22050138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancer.
    Kim GE; Lee JS; Choi YD; Lee KH; Lee JH; Nam JH; Choi C; Kim SS; Park MH; Yoon JH; Kweon SS
    BMC Cancer; 2014 Dec; 14():959. PubMed ID: 25510449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrantly upregulated TRAP1 is required for tumorigenesis of breast cancer.
    Zhang B; Wang J; Huang Z; Wei P; Liu Y; Hao J; Zhao L; Zhang F; Tu Y; Wei T
    Oncotarget; 2015 Dec; 6(42):44495-508. PubMed ID: 26517089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.
    Giordano C; Chemi F; Panza S; Barone I; Bonofiglio D; Lanzino M; Cordella A; Campana A; Hashim A; Rizza P; Leggio A; Győrffy B; Simões BM; Clarke RB; Weisz A; Catalano S; Andò S
    Oncotarget; 2016 Jan; 7(2):1262-75. PubMed ID: 26556856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression of heat shoc kproteins/factors (HSP60, HSP70, HSP90, HSF-1, HSF-3) and antioxidant enzyme activities in heat stressed broilers treated with vitamin C.
    Albokhadaim IF; Althnaian TA; El-Bahr SM
    Pol J Vet Sci; 2019 Sep; 22(3):565-572. PubMed ID: 31560472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrinsic proteotoxic stress levels vary and act as a predictive marker for sensitivity of cancer cells to Hsp90 inhibition.
    Pastorek M; Muller P; Coates PJ; Vojtesek B
    PLoS One; 2018; 13(8):e0202758. PubMed ID: 30138434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.